UAHS and UA Experts Taking Center Stage at TENWEST Impact Festival
- What: TENWEST Impact Festival
- When: Oct. 11-20
Cardiology
Regulatory Science Series Presents: ‘Direct-to-Consumer Genetic Testing’
Presented by the UA James E. Rogers College of Law and UA Health Sciences...
“Direct-to-Consumer Genetic Testing”
SPEAKERS:
Dr. Roberta Weintraut Awarded Alumna of the Year from Weil Center
Each year the Andrew Weil Center for Integrative Medicine (AWCIM) at the University of Arizona awards its Alumni of the Year award to a graduate of its educational programs who is advancing the field of integrative medicine. Open to graduates of the flagship Fellowship in Integrative Medicine, as well as the Integrative Health & Lifestyle program, nominations are solicited from previous graduates of these programs.
Medicine Grand Rounds
TOPIC: "Asthma 2019: Mechanisms to Precision Medicine"
SPEAKER: Dr. Monica Kraft
LOCATION: UAHS 5403 (LIVE) and Banner-UMC-SC 3030 (Video Conferenced)
Watch It LIVE!
(or archived here for later viewing)
UA Experts Taking Center Stage at TENWEST Impact Festival
More than 50 speakers from the University of Arizona and 250 overall will take part in TENWEST Impact Festival, which runs Oct.
UA Department of Urology to Host Inaugural Golf Benefit for Fight Against Prostate Cancer, Nov. 9
The chance of an amateur golfer making a hole-in-one on the golf course is 12,500 to one, while one in nine men will be diagnosed with prostate cancer in their lifetime.
New Study has Potential to Improve Lives of ALS Patients
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, affecting vital functions such as speech, swallowing and breathing. Commonly known as Lou Gehrig’s disease, the disorder is characterized by muscle weakness, stiffness and, eventually, paralysis.
UA Research Shows Drug Can Extend Survival Rates for Heart Failure Patients
Researchers at the University of Arizona College of Medicine – Phoenix have shown for the first time in preclinical studies that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay the progression of congestive heart failure and lengthen survival rates.
More than 5 million Americans live with congestive heart failure, a chronic progressive condition that occurs when the heart muscle doesn’t pump blood as well as it should.
University of Arizona Health Sciences’ Monica Kraft and Marti Lindsey honored with AZBio Awards
Faculty Forum: Mythbusters
Pages
